NCT07160829View on ClinicalTrials.gov

Focus on Levels of Awareness and Perceptions Regarding hsCRP in Identifying Systemic Inflammation in ASCVD, CKD and Heart Failure Management

Enrolling by invitationOBSERVATIONAL
Enrollment

608

Participants

Timeline

Start Date

September 18, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Atherosclerotic Cardiovascular DiseaseHeart FailureChronic Kidney Disease
Interventions
OTHER

No treatment given

No treatment given

Trial Locations (4)

2060

Novo Nordisk Investigational Site, Sydney

Unknown

Novo Nordisk Investigational Site, Bangalore

Novo Nordisk Investigational Site, Seoul

Novo Nordisk Investigational Site, Bangkok

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY